This trial is investigating the use of superparamagnetic iron oxide nanoparticles as a tracer for delayed sentinel lymph node dissection in patients where upfront axillary surgery is oncologically deemed unnecessary.
3 Primary · 4 Secondary · Reporting Duration: 10 years
Active Control
Experimental Treatment
500 Total Participants · 2 Treatment Groups
Primary Treatment: Delayed SLND · No Placebo Group · Phase 3
Age 18+ · Female Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: